Very-low-density lipoprotein subfraction composition and metabolism by adipose tissue

Metabolism: Clinical and Experimental

Volumn 46, Issue 6, 1997, Pages 605-610

  Fisher, Rachel M ^a   Miles, John M ^b   Kottke, Bruce A ^b   Frayn, Keith N ^b   Coppack, Simon W ^b  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN B; APOLIPOPROTEIN C1; APOLIPOPROTEIN C2; APOLIPOPROTEIN C3; LIPOPROTEIN LIPASE; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ADIPOSE TISSUE; ADULT; ARTICLE; HUMAN; HUMAN EXPERIMENT; LIPID COMPOSITION; LIPOPROTEIN BLOOD LEVEL; LIPOPROTEIN METABOLISM; MALE; NORMAL HUMAN; PRIORITY JOURNAL;

EID: 0030919969     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0026-0495(97)90001-9     Document Type: Article

References (62)

1. Marinetti GV: Disorders of Lipid Metabolism. New York, NY, Plenum, 1990, pp 75-119
2. Packard CJ, Munro A, Lorimer AR, et al: Metabolism of apolipoprotein B in large triglyceride-rich very low density lipoproteins of normal and hypertriglyceridemic subjects. J Clin Invest 74:2178-2192, 1984
3. Shepherd J, Packard CJ: Metabolic heterogeneity in very low-density lipoproteins. Am Heart J 113:503-508, 1987
4. Mahley RW, Innearity TL, Rail SC Jr, et al: Plasma lipoproteins: Apolipoprotein structure and function. J Lipid Res 25:1277-1294, 1984
5. Bradley WA, Gianturco SH: ApoE is necessary and sufficient for the binding of large triglyceride-rich lipoproteins to the LDL receptor; apoB is unnecessary. J Lipid Res 27:40-48, 1986
6. Fisher RM, Coppack SW, Gibbons GF, et al: Post-prandial VLDL subfraction metabolism in normal and obese subjects. Int J Obes 17:263-269, 1993
7. Kiens B, Lithell H: Lipoprotein metabolism influenced by traininginduced changes in human skeletal muscle. J Clin Invest 83:558-564, 1989
8. Rössner S, Eklund B, Kaijser L, et al: Removal of exogenous plasma triglycerides in forearm muscle and subcutaneous tissue of hyper- and normotriglyceridaemic men. Eur J Clin Invest 6:299-305, 1976
9. Potts JL, Fisher RM, Humphreys SM, et al: Chylomicrons are the preferred substrate for lipoprotein lipase in vivo. Biochem Soc Trans 19:3145, 1991
10. Cryer A: Tissue lipoprotein lipase activity and its action in lipoprotein metabolism. Int J Biochem 13:525-541, 1981
11. Potts JL, Fisher RM, Humphreys SM, et al: Peripheral triacylglycerol extraction in the fasting and post-prandial states. Clin Sci 81:621-626, 1991
12. Coppack SW, Yost TJ, Fisher RM, et al: Periprandial systemic and regional lipase activity in normal man. Am J Physiol 270:E718-E722, 1996
13. Coppack SW, Frayn KN, Humphreys SM, et al: Arteriovenous differences across human adipose tissue and forearm tissues after overnight fast. Metabolism. 38:1-7, 1989
14. Potts JL, Coppack SW, Fisher RM, et al: Impaired postprandial lipoprotein clearance of triacylglycerol-rich lipoproteins in adipose tissue in obese subjects. Am J Physiol 268:E588-E594, 1995
15. Frayn KN, Coppack SW, Humphreys SM, et al: Metabolic characteristics of human adipose tissue in vivo. Clin Sci 76:509-516, 1989
16. Humphreys SM, Fisher RM, Frayn KN: Micro-method for measurement of sub-nanomole amounts of triacylglycerol. Ann Clin Biochem 27:597-598, 1990
17. Au YPT, Bren ND, Kottke BA: A rapid apolipoprotein E radioimmunoassay using solid-phase Staphylococcus protein. Use of pooled plasma as a secondary standard. Biochem Biophys Res Commun 138:455-462, 1986
18. Bren ND, Rastogi A, Kottke BA: Quantification of human apolipoproteins C-I, C-II and C-III by radioimmunoassays. Mayo Clin Proc 68:657-664, 1993
19. Hallaway BJ, Rastogi A, Kottke BA: Quantification of apolipoprotein B using particle concentration fluorescence immunoassay. Clin Chem 38:2387-2391, 1992
20. Kane JP, Hardman DA, Paulus HE: Heterogeneity of apolipoprotein B: Isolation of a new species from human chylomicrons. Proc Natl Acad Sci USA 77:2465-2469, 1980
21. Elovson J, Chatterton JE, Bell GT, et al: Plasma very low density lipoproteins contain a single molecule of apolipoprotein B. J Lipid Res 29:1461-1473, 1988
22. Packard CJ, Boag DE, Clegg R, et al: Effects of 1,2-cyclohexanedione modification on the metabolism of very low density lipoprotein apolipoprotein B: Potential role of receptors in intermediate density lipoprotein catabolism. J Lipid Res 26:1058-1067, 1985
23. Conn JS, Wagner DA, Cohn SD, et al: Measurement of very low density and low density lipoprotein apolipoprotein (apo) B-100 and high density lipoprotein apo A-I production in human subjects using deuterated leucine. J Clin Invest 85:804-811, 1990
24. Rubin L, Aladjem F: Serum lipoprotein changes during fasting in man. Am J Physiol 178:263-266, 1954
25. National Institutes of Health: Manual of Laboratory Operations: Lipid Research Clinics Program: I. Lipid and Lipoprotein Analysis. Bethesda, MD, US Department of Health, Education, and Welfare, Publication No. (NIH) 75-628, 1974
26. Taskinen M-R, Kashyap ML, Srivastava LS, et al: In vitro catabolism of human plasma very low density lipoproteins. Effects of VLDL concentration on the interconversion of high density lipoprotein subfractions. Atherosclerosis 41:381-394, 1982
27. LaRosa JC, Levy RI, Brown WV, et al: Changes in high density lipoprotein protein composition after heparin-induced lipolysis. Am J Physiol 220:785-791, 1971
28. Rubenstien A, Gibson JC, Patemiti JR Jr, et al: Effect of heparin-induced lipolysis on the distribution of apolipoprotein E among lipoprotein subclasses. Studies with patients deficient in hepatic triglyceride lipase and lipoprotein lipase. J Clin Invest 75:710-721, 1985
29. Gibson JC, Brown WV: Effect of lipoprotein lipase and hepatic triglyceride lipase activity on the distribution of apolipoprotein E among the plasma lipoproteins. Atherosclerosis 73:45-55, 1988
30. Eisenberg S: Plasma lipoprotein conversions: The origin of low-density and high-density lipoproteins. Ann NY Acad Sci 348:30-47, 1980
31. Havel RJ, Kane JP, Kashyap ML: Interchange of apolipoproteins between chylomicrons and high density lipoproteins during alimentary lipemia in man. J Clin Invest 52:32-38, 1973
32. Musliner TA, Herbert PN, Kingston MJ: Lipoprotein substrates of lipoprotein lipase and hepatic triacylglycerol lipase from human post-heparin plasma. Biochim Biophys Acta 575:277-288, 1979
33. Fisher RM, Coppack SW, Humphreys SM, et al: Human triacylglycerol-rich lipoprotein subfractions as substrates for lipoprotein lipase. Clin Chim Acta 236:7-17, 1995
34. Streja D, Kallai MA, Steiner G: The metabolic heterogeneity of human very low density lipoprotein triglyceride. Metabolism 26:1333-1344, 1977
35. Manzato E, Zambon S, Marin R, et al: Modifications of plasma lipoproteins after lipase activation in patients with chylomicronemia. J Lipid Res 27:1248-1258, 1986
36. Demant T, Gaw A, Watts GF, et al: Metabolism of apoB-100-containing lipoproteins in familial hyperchylomicronemia. J Lipid Res 34:147-156, 1993
37. Saheki S, Takahashi I, Murase M, et al: Composition of very low density lipoproteins and in vitro effects of lipoprotein lipase. Clin Chim Acta 204:155-166, 1991
38. Breckenridge WC, Little JA, Steiner G, et al: Hypertriglyceridemia associated with deficiency of apolipoprotein C-II. N Engl J Med 298:1265-1273, 1978
39. Brown WV, Baginsky ML: Inhibition of lipoprotein lipase by an apoprotein of human very low density lipoprotein. Biochem Biophys Res Commun 46:375-382, 1972
40. McConathy WJ, Gesquiere JC, Tartar A, et al: Inhibition of lipoprotein lipase by synthetic peptides of apolipoprotein C-III. J Lipid Res 33:995-1003, 1992
41. Kashyap ML, Barnhart RL, Srivastava LS, et al: Effects of dietary carbohydrate and fat on plasma lipoproteins and apolipoproteins C-II and C-III in healthy men. J Lipid Res 23:877-886, 1982
42. Lambert D, Max JP, Mejean L, et al: Correlations between the apoprotein C composition of very-low-density lipoproteins and triglyceridemia in subjects with type IV hyperlipoproteinemia. J Lab Clin Med 97:834-841, 1981
43. Le N-A, Gibson JC, Ginsberg HN: Independent regulation of plasma apolipoprotein C-II and C-III concentrations in very low density and high density lipoproteins: Implications for the regulation of the catabolism of these lipoproteins. J Lipid Res 29:669-677, 1988
44. Carlson LA, Ballantyne D: Changing relative proportions of apolipoproteins CII and CIII of very low density lipoproteins in hypertriglyceridaemia. Atherosclerosis 23:563-568, 1976
45. Eisenberg S, Patsch JR, Sparrow JT, et al: Very low density lippprotein. Removal of apolipoproteins C-II and C-III-1 during lipolysis in vitro. J Biol Chem 254:12603-12608, 1979
46. Aaltp-Setälä K, Fisher EA, Chen X, et al: Mechanism of hypertriglyceridemia in human apolipoprotein (apo) CIII transgenic mice. Diminished very low density lipoprotein fractional catabolic rate associated with increased apo CIII and reduced apo E on the particles. J Clin Invest 90:1889-1900, 1992
47. Sehayek E, Eisenberg S : Mechanisms of inhibition by apolipoprotein C of apolipoprotein E-dependent cellular metabolism of human triglyceride-rich lipoprotein through the low density lipoprotein receptor pathway. J Biol Chem 266:18259-18267, 1991
48. Sata T, Havel RJ, Jones AL: Characterization of subfractions of triglyceride-rich lipoproteins separated by gel chromatography from blood plasma of normolipemic and hyperlipemic humans. J Lipid Res 13:757-768, 1972
49. Kuchinskiene Z, Carlson LA: Composition, concentration, and size of low density lipoproteins and of subfractions of very low density lipoproteins from serum of normal men and women. J Lipid Res 23:762-769, 1982
50. Redgrave TG, Carlson LA: Changes in plasma very low density and low density lipoprotein content, composition, and size after a fatty meal in normo- and hypertriglyceridemic man. J Lipid Res 20:217-229, 1979
51. Demant T, Bedford D, Packard CJ, et al: Influence of apolipoprotein E polymorphism on apolipoprotein B-100 metabolism in normolipemic subjects. J Clin Invest 88:1490-1501, 1991
52. Kane JP, Sata T, Hamilton RL, et al: Apolipoprotein composition of very low density lipoproteins of human serum. J Clin Invest 56:1622-1634, 1975
53. Karpe F, Steiner G, Olivecrona T, et al: Metabolism of triglyceriderich lipoproteins during alimentary lipemia. J Clin Invest 91:748-758, 1993
54. Coppack SW, Fisher RM, Gibbons GF, et al: Postprandial substrate deposition in human forearm and adipose tissues in vivo. Clin Sci 79:339-348, 1990
55. Eckel RH: Lipoprotein lipase. A multifunctional enzyme relevant to common metabolic diseases. N Engl J Med 320:1060-1068, 1989
56. Coppack SW, Evans RD, Fisher RM, et al: Adipose tissue metabolism in obesity: Lipase action in vivo before and after a mixed meal. Metabolism 41:264-272, 1992
57. Tall AR: Plasma high density lipoproteins. Metabolism and relationship to atherogenesis. J Clin Invest 86:379-384, 1990
58. Brasaemele DL, Comely-Moss K, Bensadoun A: Hepatic lipase treatment of chylomicron remnants increases exposure of apolipoprotein E. J Lipid Res 34:455-465, 1993
59. Marcovina SM, Albers JJ: Standardization of the immunochemical determination of apolipoproteins A-I and B: A report on the International Federation of Clinical Chemistry meeting on standardization of apolipoprotein A-I and B measurements (basis for future consensus), Vienna, Austria, April 18-19, 1989. Clin Chem 35:2009-2015, 1989
60. Levy E, Deckelbaum RJ, Thibault RL, et al: In vitro remodelling of plasma lipoproteins in whole plasma by lipoprotein lipase in primary and secondary hypertriglyceridaemia. Eur J Clin Invest 20:422-431, 1990
61. Mahley RW: Apolipoprotein E: Cholesterol transport protein with expanding role in cell biology. Science 240:622-630, 1988
62. Rosenfeld ME, Butler S, Ord VA, et al: Abundant expression of apoprotein E by macrophages in human and rabbit atherosclerotic lesions. Arterioscler Thromb 13:1382-1389, 1993